243 related articles for article (PubMed ID: 32614981)
1. Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
Sathe G; Albert M; Darrow J; Saito A; Troncoso J; Pandey A; Moghekar A
J Neurochem; 2021 Mar; 156(6):988-1002. PubMed ID: 32614981
[TBL] [Abstract][Full Text] [Related]
2. Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.
Sathe G; Mangalaparthi KK; Jain A; Darrow J; Troncoso J; Albert M; Moghekar A; Pandey A
OMICS; 2020 Apr; 24(4):216-227. PubMed ID: 32182160
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology.
Montero-Calle A; Coronel R; Garranzo-Asensio M; Solís-Fernández G; Rábano A; de Los Ríos V; Fernández-Aceñero MJ; Mendes ML; Martínez-Useros J; Megías D; Moreno-Casbas MT; Peláez-García A; Liste I; Barderas R
Cell Mol Life Sci; 2023 May; 80(6):141. PubMed ID: 37149819
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
Chen M; Xia W
J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
[TBL] [Abstract][Full Text] [Related]
6. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.
Gozal YM; Duong DM; Gearing M; Cheng D; Hanfelt JJ; Funderburk C; Peng J; Lah JJ; Levey AI
J Proteome Res; 2009 Nov; 8(11):5069-79. PubMed ID: 19746990
[TBL] [Abstract][Full Text] [Related]
8. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
[TBL] [Abstract][Full Text] [Related]
9. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated tau interactome in the human Alzheimer's disease brain.
Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
[TBL] [Abstract][Full Text] [Related]
11. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
[TBL] [Abstract][Full Text] [Related]
12. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
13. Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice.
Nilsson P; Loganathan K; Sekiguchi M; Winblad B; Iwata N; Saido TC; Tjernberg LO
Proteomics; 2015 Oct; 15(19):3349-55. PubMed ID: 26194619
[TBL] [Abstract][Full Text] [Related]
14. Disease state, age, sex, and post-mortem time-dependent expression of proteins in AD vs. control frontal cortex brain samples.
Müller T; Jung K; Ullrich A; Schrötter A; Meyer HE; Stephan C; Egensperger R; Marcus K
Curr Alzheimer Res; 2008 Dec; 5(6):562-71. PubMed ID: 19075583
[TBL] [Abstract][Full Text] [Related]
15. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.
Liang WS; Dunckley T; Beach TG; Grover A; Mastroeni D; Ramsey K; Caselli RJ; Kukull WA; McKeel D; Morris JC; Hulette CM; Schmechel D; Reiman EM; Rogers J; Stephan DA
Physiol Genomics; 2008 Apr; 33(2):240-56. PubMed ID: 18270320
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.
Donovan LE; Higginbotham L; Dammer EB; Gearing M; Rees HD; Xia Q; Duong DM; Seyfried NT; Lah JJ; Levey AI
Proteomics Clin Appl; 2012 Apr; 6(3-4):201-11. PubMed ID: 22532456
[TBL] [Abstract][Full Text] [Related]
17. Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
Musunuri S; Khoonsari PE; Mikus M; Wetterhall M; Häggmark-Mänberg A; Lannfelt L; Erlandsson A; Bergquist J; Ingelsson M; Shevchenko G; Nilsson P; Kultima K
J Alzheimers Dis; 2016 Oct; 54(4):1671-1686. PubMed ID: 27636840
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
[TBL] [Abstract][Full Text] [Related]
20. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease.
Ping L; Kundinger SR; Duong DM; Yin L; Gearing M; Lah JJ; Levey AI; Seyfried NT
Sci Data; 2020 Sep; 7(1):315. PubMed ID: 32985496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
